Market Tracker

06/24 5:16pm ET

Galapagos NV (NASDAQ:GLPG)

51.12
Delayed Data
As of Jun 24
 -2.93 / -5.42%
Today’s Change
37.03
Today|||52-Week Range
65.70
-18.70%
Year-to-Date
3 Reasons Gilead Sciences Is a Buy
Jun 17 / MotleyFool.com - Paid Partner Content
My Favorite Clinical-Stage Biotech Stocks to Buy
Jun 11 / MotleyFool.com - Paid Partner Content
3 Biotech Stocks to Buy If the Market Crashes
Jun 14 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close54.05
Today’s open50.31
Day’s range50.20 - 52.12
Volume492,372
Average volume (3 months)80,434
Market cap$2.1B
Dividend yield--
Data as of 4:00pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)-143.26%
Earnings growth (this year)--
Earnings growth (next 5 years)-77.90%
Revenue growth (last year)-52.36%
P/E ratio--
Price/Sales51.41
Price/Book5.33

Competitors

 Today’s
change
Today’s
% change
TSROTESARO Inc-1.95-4.32%
MYGNMyriad Genetics Inc-0.76-2.47%
RAREUltragenyx Pharmaceu...-2.78-5.35%
IPXLImpax Laboratories I...-1.07-3.53%
Data as of 4:00pm ET, 06/24/2016

Financials

Next reporting dateJuly 29, 2016
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$43.7M
Annual profit (last year)-$130.7M
Net profit margin-299.29%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Executive Director
Onno van de Stolpe
Chief Financial Officer
Bart Filius
Corporate headquarters
Mechelen, Brussels Region

Forecasts